(Q33822641)

English

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Alzheimer's disease

0 references

cerebrospinal fluid

0 references

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

dementia with Lewy bodies

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Henrik Zetterberg

4

object named as

Henrik Zetterberg

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5

object named as

Kaj Blennow

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Elisabet Londos

8

object named as

Elisabet Londos

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lennart Minthon

6

object named as

Lennart Minthon

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Katarina Nägga

7

object named as

Katarina Nägga

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2

object named as

Sara Hall

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Annika Ohrfelt

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Shiji Varghese

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Nour K Majbour

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Abdulmonem Al-Hayani

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Omar Ma El-Agnaf

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

7 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Alzheimers Research & Therapy

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

https://scigraph.springernature.com/pub.10.1186/alzrt255

0 references

Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Elevated levels of α-synuclein oligomer in the cerebrospinal fluid of drug-naïve patients with Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Pathological roles of α-synuclein in neurological disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Analytical error and interference in immunoassay: minimizing risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

α-Synuclein in Parkinson disease and other neurodegenerative disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

In vivo demonstration that alpha-synuclein oligomers are toxic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Oligomeric alpha-synuclein and its role in neuronal death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Cognitive dysfunction and dementia in Parkinson disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Clinical diagnostic criteria for dementia associated with Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Global prevalence of dementia: a Delphi consensus study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

4 July 2018

Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1186%2FALZRT255

21 January 2018

Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1186%2FALZRT255

21 January 2018

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.

1 reference

https://api.crossref.org/works/10.1186%2FALZRT255

21 January 2018

alpha-Synuclein gene duplication is present in sporadic Parkinson disease.

1 reference

https://api.crossref.org/works/10.1186%2FALZRT255

21 January 2018

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.

1 reference

https://api.crossref.org/works/10.1186%2FALZRT255

21 January 2018

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1186%2FALZRT255

21 January 2018

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

29 October 2018

DLB and PDD: a role for mutations in dementia and Parkinson disease genes?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

29 October 2018

The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

29 October 2018

CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

29 October 2018

Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

29 October 2018

Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

29 October 2018

Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-Aβ Antibodies

1 reference

https://api.crossref.org/works/10.1186%2FALZRT255

21 January 2018

Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

1 reference

https://api.crossref.org/works/10.1186%2FALZRT255

21 January 2018

Interference from heterophilic antibodies in amyloid-β oligomer ELISAs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4075410

29 October 2018

Clues to how alpha-synuclein damages neurons in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24987465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24987465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24987465

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/ALZRT255

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/alzrt255

9 September 2019

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33822641&oldid=1960736690"